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Limited research suggests that indirect moxibustion may be beneficial for treating fa-
tigue, but no studies to evaluate direct moxibustion have been conducted in the United
States. Thus, we explored the usefulness of four outcome measures for evaluating the
effectiveness of direct moxibustion for patients with spleen qi and yang deficiency fa-
tigue (SQYDF). Eleven female volunteers, ages 25e60 years, were enrolled. Three to five
rice grains in thread-sized moxa cones were burned on 11 acupuncture points once per
week for 8 weeks. Eight participants completed the study. The most common adverse
events (AEs) were temporary worsening of fatigue, lightheadedness, and headache.
Symptomatic improvement was seen on the SF-36 energy/fatigue scale (p Z 0.003),
SF-36 social function scale (p Z 0.008) and Flinders fatigue scale (p Z 0.014). The skin
conductance at acupoints showed no consistent diagnostic baseline meridian patterns.
Heart rate variability data showed an improved low frequency/high frequency (LF/HF) ra-
tio in three of four participants. Direct moxibustion is safe in patients with SQYDF. The
Flinders Fatigue Scale (FFS) and the SF-36 are useful outcome measures for evaluating
the effects of direct moxibustion, and the heart rate variability (HRV) may be, but the
skin conductance did not correlate with SQYDF diagnosis or with symptomatic
improvement.llege of Natural Medicine, Helfgott Institute, Helfgott, 2220 SW 1st Avenue, Portland, OR 97201, USA.
. Thorne).
e, Portland, OR 97202, USA.
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Direct moxibustion in treating fatigue 771. Introduction
Moxibustion is an essential treatment modality in tradi-
tional Chinese medicine, with roots that may be older than
the use of acupuncture needles. A survey of classical
medical literature reveals centuries of writing on the clin-
ical application and benefits of at least 20 different forms
of moxibustion [1].
Despite the long appreciated clinical benefits of moxi-
bustion, its use appears to be undervalued in the US. As
reasons for not utilizing moxibustion therapy, practitioners
cite time commitment, exposure to smoke and the lack of
US malpractice insurance coverage for some forms of
moxibustion (direct) [2]. In contrast to the US, the use of
moxibustion for a myriad of diseases and conditions is still
widespread in East Asia. In Japan, which separates
licensures for acupuncture and moxibustion, a common
form of moxibustion is called tonnetsukyu (“scarring”,
“penetrating” or okyu) [3]. Practitioners form tiny moxa
cones weighing approximately 1 mg and ranging in size from
a “rice grain” to a “thread” [4]. The cone is placed on the
skin, with either a drop of water or ointment as a barrier,
and burned down to the skin. In Japan, the species of moxa
used for moxibustion is Artemisia princeps, which is refined
and aged for long periods of time. The resulting grade of
moxa produces less smoke and odor and combusts at a
lower temperature than other grades of moxa [5]. A well
known moxa treatment in Japan was developed by Sawada
Ken in the early 20th century, after years of studying mox-
ibustion in Korea. Called taikyoku (Ch. taiji), this treat-
ment utilizes a core set of acupoints with modifications
based on the clinical presentation of the patient [6e8].
Fukaya Isaburo is another modern moxibustionist who
introduced the practice of placing a bamboo tube over
burning moxa cones, to provide deeper penetration of the
therapeutic stimulus [9].
Though some clinical research on direct moxibustion has
been conducted in Japan and Korea, the few articles
available in English are basic science studies [10,11].
Research on moxibustion in China has primarily investigated
the use of indirect moxa (moxa poles, moxa on the needle,
and moxa cones placed on various mediums such as garlic,
ginger or aconite) [12]. One clinician, Guang-Rong Li, is
investigating direct moxa, but unlike the technique used in
our study the cones are much larger and the dose he pro-
poses involves intentional blistering and suppuration [13]. A
paucity of moxa research is available in the US, with no
published studies of the direct moxibustion technique.
Clinically, moxibustion is frequently used to treat fa-
tigue from spleen qi and yang deficiency. This is a common
diagnosis in Western acupuncture clinics due to the un-
healthy effects of modern diet and lifestyle [14], and
closely aligns with the common complaint of fatigue seen in
many biomedical clinics [15]. At the acupuncture and
naturopathic clinics of the National College of Natural
Medicine (NCNM), the diagnosis of fatigue and malaise de-
scribes the most common chief complaint. Evidence from a
systematic review of 40 moxibustion studies and a single
study utilizing both moxa and psychological intervention,
supports the use of indirect moxibustion for treating pa-
tients with the western medical diagnosis chronic fatiguesyndrome (CFS) [12,16]. However, few previous studies
have assessed moxibustion as a sole intervention for fatigue
and no studies have evaluated the use of direct moxibustion
for treating spleen qi and yang deficiency fatigue (SQYDF).
In addition, no previous study has specifically addressed
patient tolerance and adverse events (AEs) associated with
direct moxibustion.
Given the lack of available published research on direct
moxibustion for SQYDF, minimal reporting on patient
tolerability or AEs and the current reluctance to utilize
direct moxibustion in the US, we set out to test a meth-
odological approach for conducting a human study utilizing
the combined Sawada/Fukaya protocol-technique to treat
the common clinical complaint of fatigue.
Our goal was to answer the following questions:
 Can patients with SQYDF be recruited and retained in
an 8-week clinical trial of direct moxibustion?
 Is the direct moxibustion technique safe and tolerable
in US participants?
 What experience do patients report when direct moxi-
bustion is applied?
 Will a standardized taikyoku direct moxibustion proto-
col administered once per week for 8 weeks provide
symptomatic improvement in patients with SQYDF?
 Do the outcome measures SF-36 and Flinders Fatigue
Scale (FFS) characterize symptomatic change associ-
ated with direct moxibustion treatments?
 Is there a consistent skin conductance (SC) pattern
among the 24 Source acupoints in patients diagnosed
with SQYDF?
 Do SC patterns at the 24 Source acupoints change as a
result of eight direct moxibustion treatments?
 Will heart rate variability (HRV) change as a result of a
series of direct moxibustion treatments in this partici-
pant sample?2. Materials and methods
The study was approved by the NCNM Institutional Review
Board. Both genders were recruited from the local com-
munity utilizing posters at businesses and libraries and
postings on the NCNM website. All participants signed an
informed consent. There was no compensation for partici-
pation in the study. The study was conducted between
March and August 2011 at NCNM’s Helfgott Research
Institute.
2.1. Inclusion and exclusion
Telephone screening and in-person physical examination
determined whether potential participants met the
following symptomatic criteria: complaints of fatigue, lack
of energy/strength/vitality, lack of concentration, a feeling
of being cold, and loose stools. Physical examination inclu-
sion criteria were: findings of a puffy, pale, swollen or scal-
loped tongue, palpatory coolness in the lower abdomen, or
weakness in the area of acupoints CV12eCV6, and a spleen
deficient pulse pattern. The pulse analysis utilized is known
Figure 1 Bamboo boards, jointed bamboo tube and one
length of pre-rolled moxa.
Figure 2 Rice grain cone of moxa on Shiunko cream.
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Meridian Therapy (JMT) acupuncture [17]. The abdominal
diagnosis (fukushin) utilized is also derived from JMT, which
refers to the abdominal reflex zones from chapter 16 of the
classical Chinesemedical text theNan Jing. Tongue diagnosis
was used according to Traditional Chinese Medicine (TCM)
practice. Excluded were individuals who had an acute or
chronic illness including CFS, those diagnosed with Epstein-
Barr or Lyme disease, or chronic parasitic diseases, or
those on psychotropic drugs. Also excluded were individuals
who had experienced acupuncture or moxa treatments
during the previous 6 months and those whose physical ex-
amination suggested multiple TCM diagnoses that
confounded a primary diagnosis of spleen qi and/or yang
deficiency (e.g., pronounced blood stagnation or qi stagna-
tion that resulted in heat signs).
2.2. Moxibustion test screening session
The direct moxibustion intervention was described to po-
tential participants as follows: “Direct moxibustion involves
burning a small amount of the dried leaves of a plant at
acupuncture points on the skin. The moxa is placed on a
smear of protective ointment, then lit with an incense stick
and snuffed out. People who receive moxibustion report a
warming sensation at the site, though sometimes they report
a momentary stinging sensation.”. Potential participants
were then asked if they would be willing to experience a test
session of moxibustion. The acupuncturist who performed
the screening, had been licensed for 6 years for clinical
evaluations and treatments, and had been trained in both
TCM and JMT. She first demonstrated direct moxibustion on
herself at the left LI11 acupoint using a transparent test tube
over the moxa, so that the participant could observe the
burning moxa cone. Participants then received a test direct
moxa treatment at four non-acupuncture skin sites (lower
arm, abdomen, shin and back). If after the test session they
werewilling to initiate the 8-week course of treatment, they
were enrolled in the study.
2.3. Intervention
For 8 sequential weeks, on the same day, at approximately
the same time of day, participants received direct moxi-
bustion as a sole intervention for SQYDF. During the first
three treatments, three moxa cones (rice grain to thread
size) were burned at each of 11 acupoints. For treatments
4e8, five moxa cones were burned at each acupoint. Acu-
points were treated in the following order: left TE4 (back of
the wrist on the crease), CV12 (midway between the navel
and sternum), bilateral ST36 (just below the knee), GV12
(below the spinous process of T3), bilateral BL20 (at the level
of the 11th thoracic vertebra on the back), bilateral BL23 (at
the level of the 3rd lumbar vertebra on the back), and
bilateral LI11 (at the lateral elbow). The low back points
were administered in a cross-cross pattern (R BL20, L BL23, L
BL20, R BL23). Acupoint location was determined by using
the standard point location definitions and palpation of the
site for skin texture changes (moisture, tension, depression).
The moxa was pre-rolled using two bamboo boards
(11  8 cm) (Fig. 1). A small amount of “purple cloudointment” (Shiunko) was first placed on the skin. Shiunko
contains dang gui (Angelica sinensis), zi cao gen (Lith-
ospermum spp.), sesame oil, and beeswax. The width of the
Shiunko smear was slightly larger than the circumference of
the tinymoxa cone (approximately 0.5e2mm). The conewas
litwith incense (Seiun Joss sticks) and then covered overwith
a jointed bamboo tube (diameter of 13e14 mm, approxi-
mately 3 cm to one joint in bamboo, 7 cm for the opposite
end) (Fig. 2). The tube remained on the skin until the moxa
stopped burning (about 2e3 seconds). The remaining ashwas
flattened and left in place. Additional moxa cones were
stacked on top of this until the desired number of cones had
been burned. Initially, the short end of the bamboo tube was
placed over the lit moxa cone. If the participant reported a
muted sensation of heat, then the long end of the tube was
used to allow for more oxygen and thereby increase the felt
heat. Thismodificationwas recorded in theparticipant’s file.
Research determining the most efficacious dose of “felt
heat” from moxibustion is limited [18,19]. Clinically,
practitioners vary in their recommended degree of felt heat
required to deliver an effective dose of direct moxibustion,
which ranges from the patient not needing to feel anything,
to a required sensation of “hot”. In this study, a specific
range of sensations was described to the participant, which
spanned feeling “at least some sense of warmth” to a “zip”
or “sting” that “should last only momentarily” with each
cone. If the participant perceived the stimulus to be
outside of this range, then she was urged to tell the prac-
titioner, so that the cone density, size, end of tube, or how
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be modified. The acupuncturist repeatedly checked with
participants to ensure that they were in the “dosage
range.”
One acupuncturist (TT) performed all moxibustion
treatments. At each treatment, she first reviewed any AEs
reported by the participant from a prespecified symptom
checklist. The checklist was developed from a systematic
review of AEs associated with moxibustion [20]. Each
treatment took approximately 15 minutes. Each study visit
lasted a total of 30 minutes.
2.4. Outcome measures
Two subjective and two objective outcome measures were
evaluated for their usefulness in a future clinical trial. The
FFS and the SF-36 were administered at baseline and study
completion. SC measurements at the 24 Source acupoints
were obtained at each study visit and electrocardiographic
(ECG) readings for HRV were obtained at baseline and study
completion.
2.4.1. The FFS
The FFS [21] is a 7-item scale that measures various char-
acteristics of fatigue experienced over the past 2 weeks.
The items tap into commonly reported themes of how
problematic fatigue is, the consequences of fatigue, fre-
quency, severity, and patients’ perception of fatigue’s as-
sociation with sleep. Six items are presented in Likert
format, with responses ranging from 0 (not at all) to 4
(extremely). Total fatigue scores range from 0 to 31, with
higher scores indicating greater fatigue. A clear description
of the term “fatigue” is provided in the initial instructions
to the scale.
2.4.2. The short form SF-36
The short form SF-36 [22] is a self-administered, 36-item
questionnaire that measures health-related quality of life
in eight domains: physical functioning, limitations due to
physical problems, bodily pain, general health, vitality,
social functioning, limitations due to emotional problems,
and mental health. Each domain is scored separately from
0 (worst score) to 100 (best score). Two summary scores
(Physical Function and Mental Health Summary) can be
calculated from information obtained in the 8 domains.
2.4.3. Skin conductance
SC at the 24 Source points (Yuan) on the wrists and ankles
was obtained with the AcuGraph 3 Digital Meridian Imaging
System (Miridia Technology, Inc, Meridian, ID 83646, USA).
This system, which consists of software, an electronic
control unit, and a probe set (ground and probe), electri-
cally measures galvanic skin resistance. The software then
calculates and reports the conductance at each measured
point in normalized units (nu). The system was chosen
because of its proven single operator reliability (r Z 0.86)
for measuring conductance at the Source acupoints [23].
2.4.4. HRV
HRV data was used to assess possible autonomic nervous
system changes associated with the stimulation ofacupoints [24]. Electrocardiograph interbeat intervals were
acquired with the J & J Engineering I-330-C2þ 12 channel
biofeedback system (J & J Engineering, Inc, Poulsbo, WA,
USA). At baseline and 1 week after completing the final
moxibustion treatment, participants were instrumented
with the ECG leads of the system while 6 minutes of data
were collected. The middle 5 minutes of data were
analyzed for total variability and low frequency/high fre-
quency ratio (LF/HF). The HRV software provided by
Biomedical Signal Analysis Group, Department of Applied
Physics, University of Kuopio, Kuopio, Finland was used to
interpret the J & J signals.
2.5. Statistical analysis
For this exploratory study, we used descriptive statistics to
summarize recruitment, retention, and compliance, and to
document AEs. Pre- to post-symptomatic changes were
analyzedwith paired t tests in order to test for significance of
changes over the course of the trial. Limited HRV data were
analyzed for effect size relative to standard deviation. A
post-study anonymous survey was used to assess participant
satisfaction. Analysis of SC data for individual Source points
and left-right averages was conducted, using repeated
measures ANOVA, to determine significant differences at any
time points, and linear regression on time point, and to test
for consistent changes across time. Yineyang, lefteright,
and upperelower difference data, once computed fromdata
on appropriate Source points, were assessed with simple t
tests in order to test the significance of changes from the
beginning to the end of the trial. Although analysis of SC data
involved a large number of tests, the goal was largely to
describe outcomes, since it was quickly apparent that trends
did not support hypothesized effects. All analyses were
carried out using SPSS v. 19.
3. Results
During a 3-month recruitment period, 26 individuals
responded to posted advertisements. Initial history and
physical examination screenings yielded 13 females whomet
the SQYDF diagnostic criteria. Twelve completed an in-
person screening, which included tongue, pulse and
abdominal examination and a test moxibustion session. One
individual declined to initiate the series of treatments due
to feeling unwell the day after her test session. She believed
the fluorescent lights in the lab or the moxibustion may have
been the cause. Eleven female participants, aged 25e60
years, were ultimately enrolled. Eight enrollees completed
seven of the required eight moxibustion treatments to be
considered completers. Threewerewithdrawn: one because
she sought additional acupuncture for an unrelated symp-
tom, the second because of a self-perceived allergic reac-
tion and the third because of a desire to pursue homeopathy
for a different physical complaint.
The moxibustion treatment was generally well tolerated
among study participants. AEs were minimal; seven of 11
participants had at least one temporary episode of wors-
ening of fatigue. For all participants (completers and non-
completers), the most frequently occurring AEs were tem-
porary worsening of fatigue (n Z 27 occurrences among 7
Table 1 SF-36 and Flinders Fatigue Scale symptomatic
outcome measures.
SF-36 Sub-scale Pre* Post* p
Physical function 63.3 (25.5) 73.3 (21.8) 0.198
Role of physical function 40.3 (30.5) 59.0 (28.3) 0.041
Bodily pain 61.8 (26.6) 73.7 (21.0) 0.021
General health 44.4 (20.5) 45.8 (20.6) 0.408
Vitality 23.9 (9.3) 43.1 (13.9) 0.003z
Social function 33.3 (24.2) 64.6 (23.8) 0.008y
Role-emotional 62.5 (23.0) 64.4 (19.4) 0.758
Mental Health 52.9 (16.7) 58.7 (14.3) 0.021
Flinders Fatigue 26.1 (4.0) 17.9 (7.7) 0.014y
* All entries are mean (standard deviation).
y Statistically significant (p < 0.05).
z Significant after Bonferroni adjustment (p < 0.005).
Table 2 Adverse events reported.
Number of
participants
Number
of reports
Symptom (from checklist)
Reddening of skin at site of moxa
application that lasted >24 h
2 6
Blistering at site of moxa
applications
1 1
Itching sensations 3 4
Discomfort due to the smoke
or the smell of incense
and moxa
1 2
Worsening of fatigue 7 27
Stomach upset or nausea 3 4
Headache 5 7
Frequent urination 2 2
Burn at site of moxa
application
1 1
Lightheadedness 3 9
Easy bruising 3 4
Feeling ill at ease 3 5
Cough 2 2
Blurred vision 2 4
Dizziness 2 2
Change in sexual drive 3 5
Body pain 4 5
Skin rash 0 0
Other participant-reported symptoms, not on checklist
Poor sleep 1 6
Increased energy 1 3
Increased thirst 1 3
Emotional, moody 2 2
Night sweats 2 2
Constipation 1 2
“Brain ache” 1 1
Hot flash 1 1
Labored breathing 1 1
Epigastric low chest pain 1 1
Urgent bowel movement 1 1
Lack of coordination 1 1
“Brain fog” 1 1
Numb face while driving 1 1
80 T.L. Thorne et al.participants); lightheadedness occurred on nine occasions
among three participants; headache occurred seven times
among five participants. A complete list of AEs reported by
participants is shown in Table 1.
In an anonymous follow-up questionnaire, respondents
reported experiencing the treatments as “very relaxing” or
“relaxing” and all who responded expressed willingness to
participate in a future moxibustion study.
3.1. Symptomatic outcomes
One goal of this study was to determine the usefulness of
two questionnaires (FFS and the SF-36 pre-post) in patients
with SQYDF. Paired t tests for pre- to-post intervention
changes yielded compelling results for the Vitality
(p Z 0.003) and Social Function (p Z 0.008) subscales of
the SF-36, as well as for FFS (pZ 0.014). Changes in scores
on the Role-Physical, Bodily Pain, and Mental Health sub-
scales of the SF-36 also showed large effects and yielded
significance values <0.05 (Table 2). Due to the large num-
ber of tests, only the change in the Vitality subscale can be
considered significant, after an appropriate Bonferroni
adjustment (Bonferroni corrected alpha Z 0.005).
3.2. Physiological outcomes
Mean SC at baseline of the 24 acupoints for the 13 partic-
ipants who met the diagnostic criteria for SQYDF at base-
line, was 38 nu, on a scale of 0e200. At final assessment for
the eight completers, it was 52 nu. SC readings at the 24
Source acupoints showed no consistent diagnostic meridian
patterns among participants at baseline. There was also no
consistent change among the meridian patterns over the 8-
week course of the study. Overall, a wide variation in SC
readings between visits and among participants was
observed. Regression coefficients for time of measurement
were negative for most of these. Neither regression nor
repeated measures ANOVA showed significant effects of
time point on SC readings.
Due to technical difficulties, pre- and post-intervention
HRV data were available for only four of the eight study
completers. Three of these four participants showed
improvement in LF/HF ratios between pre- and post-
intervention measurement, with the LF/HF ratio reducedat the end of the trial. The mean change in LF/HF was equal
to 0.91, relative to a standard deviation of 3.11. After log
transformation of LF/HF scores, these figures become:
mean change Z 0.78; standard deviation Z 1.34.4. Discussion
Our objectives in conducting this feasibility study were to
evaluate our methodology and answer the preliminary
questions listed in the introduction. Our results indicated
adequate recruitment, retention and compliance and good
participant tolerability for the direct moxibustion treat-
ments. The dosing regimen of direct moxibustion (11 acu-
points treated once per week for 8 weeks within the
established range of felt experience) provided significant
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SF-36 vitality scale and near significant improvement as
measured by the FFS and the SF-36 Social Function Scale. In
addition to the small sample size, a possible reason for the
FFS results not reaching significance might be a less than
optimal dosing regimen. Although we obtained improve-
ment with the dosing regimen we chose, it is possible that
participants would have benefitted even more if more
acupoints were treated, more moxa cones burned at each
site, more frequent treatments (perhaps twice per week) or
more total treatments (12 rather than 8 sessions) were
provided. Furthermore, all participants received a stan-
dardized treatment protocol. Individualizing the protocol
as in clinical practice, might have resulted in added
improvement. Finally, direct moxibustion was the sole
intervention in this study. Participants may have needed
additional intervention (i.e., needle acupuncture) to
further reduce their longstanding fatigue.
The HRV data are not sufficient to yield statistical sig-
nificance, especially since HRV data cannot usually be
assumed to be normally or log-normally distributed [25],
but calculations did reveal promising effect sizes that, if
replicated in a larger study, could yield significant results.
Thus, the limited data obtained are consistent with our
belief that moxibustion treatment (like acupuncture) leads
to improved parasympathetic activity, as measured by HRV.
Changes in SC measurements at acupoints are used in
clinical practice as an aid to meridian diagnosis and to guide
acupuncture treatment options. The SC readings at the 24
Source acupoints in our SQYDF patients sample yielded
inconclusive results. Yu et al observed that individuals with
tiredness had significantly lower SC than non-tired in-
dividuals and that the decrease in SC correlates with the
degree of tiredness [26]. In our sample of SQYDF patients,
the average SC was low at baseline (38 nu), compared to
findings reported in a large patient sample. Chamberlin et al
analyzed first visit data on 6069 females who were seen by
one of 311 experienced AcuGraph users [27]. The average SC
readings of the 24 Source acupoints in a subgroup of females
aged 31 to 50 years, was 86 nu. Although these patients had a
variety of undescribed health complaints, their mean base-
line SC readings are substantially higher than those found in
our sample. SC increased from 38 nu to 52 nu over the 8-week
treatment in our sample. Because of large variations in the
changes between individuals, however, the increase among
the eight completers was not significant (paired t test of
average SC at first and final session; pZ 0.16).
Other than lowmeanbaselineSC recordings thatappeared
to correspond to symptomatic fatigue, we observed no
consistent SC patterns relative to an acupuncture meridian
diagnosis or to an organ (zang fu) diagnosis of SQYDF. Nor did
changes over the course of the study in the individual acu-
point SC, or patterns among the 24 acupoints, correlate with
the symptomatic improvement reported by our participants.
Our findings are dissimilar, however, to results reported in a
related study. Ahn et al found that measures of dispersion
(Gini and SD) in SC decreased over 8 weeks of needle
acupuncture treatment (2 sessions per week), reflecting
improved balance among the acupuncture meridians[28]. In
our study, the mean righteleft, yineyang, and upper-lower
differences all showed mean increases in SD over the
course of the trial. These results suggest either that futurestudies will require more precise methods for measurement
of SC, or that the SC recordings may be ill-suited to the
evaluation of moxibustion therapy in patients with SQYDF.5. Conclusions
In this small pilot study, burning small moxa cones directly
on the skin in the modified Sawada/Fukuya protocol-
technique is safe and tolerable for SQYDF patients when
administered by an experienced practitioner. The FFS and
SF-36 were useful outcome measures for assessing symp-
tomatic change in patients with SQYDF. A larger study is
needed to explore this further. The LF/HF ratio of HRV may
have promise as a physiological outcome measure for
studying the effects of direct moxibustion. SC at the 24
Source acupoints did not show a consistent diagnostic
pattern in patients with SQYDF and changes in SC over the
8-week treatment period did not correlate with symptom-
atic improvement. The use of SC as an objective outcome
may not be appropriate in this patient population.Disclosure statement
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